1-7 of 7
Chitra M. Hosing, M.D.
Close
Sort by
Journal Articles

EBMT Risk Score for Pre Transplant Risk Assessment in Patients with Multiple Myeloma.

Zartash Gul, MD, Hasan Khan, Qaiser Bashir, MD, Nina Shah, MD, Simrit Parmar, M.D., Yvonne T Dinh, Chitra M. Hosing, M.D., Uday R. Popat, M.D., Partow Kebriaei, M.D., Paolo Anderlini, MD, Elizabeth J Shpall, MD, Sergio Giralt, MD, Richard E. Champlin, Muzaffar H. Qazilbash, MD
Journal: Blood
Blood (2012) 120 (21): 3094.
https://doi.org/10.1182/blood.V120.21.3094.3094
Published: 2012
Journal Articles

Autologous Stem Cell Transplantation in Waldenstrom's Macroglobulinemia

Krina Patel, MD, Rima M Saliba, PhD, Nina Shah, MD, Qaiser Bashir, Sheeba K. Thomas, MD, Yvonne T Dinh, Chitra M. Hosing, M.D., Uday R. Popat, M.D., Simrit Parmar, M.D., Sergio A Giralt, MD, Richard E. Champlin, Muzaffar H. Qazilbash, MD
Journal: Blood
Blood (2012) 120 (21): 4533.
https://doi.org/10.1182/blood.V120.21.4533.4533
Published: 2012
Journal Articles

Cardiac Toxicity After High-Dose Melphlan and Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma

Zartash Gul, MD, Qaiser Bashir, MD, Yago Nieto, M.D., Ph.D., Nazeer Sherwani, Simrit Parmar, M.D., Nina Shah, MD, Yvonne T Dinh, Chitra M. Hosing, M.D., Uday R. Popat, M.D., Partow Kebriaei, M.D., Elizabeth J Shpall, MD, Sergio A Giralt, MD, Richard E. Champlin, Muzaffar H. Qazilbash, MD
Journal: Blood
Blood (2012) 120 (21): 2027.
https://doi.org/10.1182/blood.V120.21.2027.2027
Published: 2012
Journal Articles

Bortezomib and BEAM-Rituximab Reduced-Intensity Conditioning for High-Risk Lymphoma Patients Who Are Not Eligible for Nonmyeloablative Allogeneic Stem Cell Transplantation

Issa F. Khouri, MD, Saliba M. Rima, MD, Francesco Turturro, MD, Martin Korbling, MD, Celina Ledesma, Gabriela Rondon, MD, Amin M. Alousi, M.D., Paolo Anderlini, MD, Qaiser Bashir, MD, Stefan O. Ciurea, Chitra M. Hosing, M.D., Uday R. Popat, M.D., Yasmeen Charafeddine, Yasuhiro Oki, MD, Luis E Fayad, MD, Richard E. Champlin
Journal: Blood
Blood (2012) 120 (21): 4157.
https://doi.org/10.1182/blood.V120.21.4157.4157
Published: 2012
Journal Articles

A Matched Controlled Analysis of Post-Transplant Cyclophosphamide (CY) Versus Tacrolimus and Mini-Dose Methotrexate in Matched Sibling and Unrelated Donor Transplant Recipients Receiving Reduced-Intensity Conditioning: Post-Transplant CY Is Associated with Higher Rates of Acute Gvhd

Amin M. Alousi, M.D., Rima M Saliba, PhD, Julianne Chen, Borje S Andersson, MD, PhD, Issa Khouri, MD, Muzaffar H. Qazilbash, MD, Uday R. Popat, M.D., Chitra M. Hosing, M.D., Stefan O. Ciurea, Elizabeth J Shpall, MD, Roy B. Jones, MD, Ph.D., Partow Kebriaei, M.D., Yago Nieto, M.D., Ph.D., Paolo Anderlini, MD, Marcos DeLima, MD, Gabriela Rondon, Richard E. Champlin
Journal: Blood
Blood (2012) 120 (21): 4200.
https://doi.org/10.1182/blood.V120.21.4200.4200
Published: 2012
Journal Articles

Feasibility of Hematopoietic Stem Cell Collection and Cryopreservation in Waldenstrom's Macroglobulinemia

Dilshad Khan, MBBS, Krina Patel, MD, Sheeba K. Thomas, MD, Donna M. Weber, M.D., Kay B Delasalle, B.S., Chitra M. Hosing, M.D., Uday R. Popat, M.D., Qaiser Bashir, MD, Nina Shah, MD, Simrit Parmar, M.D., Richard E. Champlin, Muzaffar Qazilbash, M.D.
Journal: Blood
Blood (2012) 120 (21): 4128.
https://doi.org/10.1182/blood.V120.21.4128.4128
Published: 2012
Journal Articles

Outcomes of Adults with Acute Lymphoblastic Leukemia (ALL) Following Relapse After First Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)

Amir Hamdi, M.D., LM Poon, M.D., Rima M. Saliba, Ph.D., Gabriela Rondon, M.D., Celina Ledesma, Muzaffar Qazilbash, M.D., Chitra M. Hosing, M.D., Roy B. Jones, MD, Ph.D., Uday R. Popat, M.D., Nieto, M.D., Ph.D., Amin M. Alousi, M.D., Stefan O. Ciurea, Elizabeth J. Shpall, M.D., Richard E. Champlin, Partow Kebriaei, M.D.
Journal: Blood
Blood (2012) 120 (21): 4215.
https://doi.org/10.1182/blood.V120.21.4215.4215
Published: 2012